Sanofi

Sanofi and Orano join forces to develop next-generationradioligand medicines

Press Release – Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines. Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will … Continue reading Sanofi and Orano join forces to develop next-generationradioligand medicines

GE HealthCare

GE HealthCare to Lead Consortium on Synthetic Data Generation for AI in Healthcare

Chicago — October 13, 2024 — GE HealthCare will take a leadership role in Synthia, a consortium project to evaluate synthetic data generation methods, both for the creation of synthetic datasets and for their use in the development of artificial intelligence (AI) algorithms. GE Healthcare will join other healthcare industry organizations including Gates Ventures, NovoNordisk, and Pfizer and we well as academic partners including La … Continue reading GE HealthCare to Lead Consortium on Synthetic Data Generation for AI in Healthcare

Centra

Centra Board Appoints Richard Tugman As Permanent President & CEO

LYNCHBURG, Va., October 10, 2024–The Centra Board of Directors is pleased to announce that effective Oct. 7, Richard Tugman is appointed President & CEO of Centra Health. During an interim period in the role, Richard demonstrated the strong leadership necessary for guiding a complex health system. “Richard’s performance since his appointment in March 2024 as Interim President & CEO, in addition to his leadership in … Continue reading Centra Board Appoints Richard Tugman As Permanent President & CEO

Worldwide Clinical Trials

Worldwide Clinical Trials Appoints Kellie MacLeod as Executive Vice President, Global Quality Assurance

As CRO continues to grow, MacLeod will lead global direction and oversight of quality and compliance programs RESEARCH TRIANGLE PARK, N.C. – Kellie MacLeod has joined Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), as Executive Vice President, Global Quality Assurance, bringing over 23 years of extensive experience in clinical trials, quality assurance, and regulatory affairs. In this role, MacLeod will lead Worldwide’s global … Continue reading Worldwide Clinical Trials Appoints Kellie MacLeod as Executive Vice President, Global Quality Assurance

Sonrava Health

Sonrava Health Welcomes Back Preet Takkar as President and Chief Operating Officer

October 08, 2024 – COPPELL, Texas – Sonrava Health is proud to announce that Preet Takkar has rejoined the organization as President and Chief Operating Officer. With over 20 years of experience in the dental industry, Takkar brings with him a wealth of knowledge and leadership that will be pivotal to the next phase of Sonrava Health’s growth. Preet Takkar is no stranger to the … Continue reading Sonrava Health Welcomes Back Preet Takkar as President and Chief Operating Officer

VMG Health

VMG Health Acquires Carnahan Group, Healthcare Consulting Firm

October 09, 2024 – DALLAS – VMG Health, the leading consulting firm for healthcare business performance, is pleased to announce its acquisition of Carnahan Group, a consulting firm dedicated to transforming healthcare with innovative technology. Based in Tampa, FL, Carnahan Group will fully integrate with VMG Health’s Physician Compensation and Strategic Consulting divisions, adding its automated platforms to the firm’s comprehensive suite of solutions. VMG Health … Continue reading VMG Health Acquires Carnahan Group, Healthcare Consulting Firm

Judo Bio

Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

STRIKE platform to deliver siRNA and other genetic medicines to the kidney for the treatment of systemic diseases and renal diseases Lead pipeline programs use megalin receptors for intracellular delivery of ligand-siRNA conjugates to specific kidney cells to target and silence genes, including solute carrier proteins CAMBRIDGE, Mass., October 7, 2024 — Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced … Continue reading Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

Iridex

Iridex Appoints Patrick Mercer as Chief Executive Officer

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the appointment of Patrick Mercer as the Company’s Chief Executive Officer and President effective October 1, 2024. Previously Mr. Mercer served as the Company’s Chief Operating Officer and President. David Bruce, the Company’s prior Chief Executive … Continue reading Iridex Appoints Patrick Mercer as Chief Executive Officer